Roche teams up with research institutions for new Alzheimer’s trial
The trial aims to evaluate the potential of gantenerumab to slow disease progression in people with the earliest biological signs…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.